The company's US-based subsidiary has received final approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of PF Prism CV's Rapamune tablets, Glenmark Pharmaceuticals said in a statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3o73pNA
via IFTTT
0 comments:
Post a Comment